Insider Transactions in Q3 2021 at Crinetics Pharmaceuticals, Inc. (CRNX)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 08
2021
|
Matthew K Fust |
SELL
Open market or private sale
|
Direct |
6,046
-32.54%
|
$151,150
$25.5 P/Share
|
|
Sep 08
2021
|
Matthew K Fust |
BUY
Exercise of conversion of derivative security
|
Direct |
6,046
+24.55%
|
$6,046
$1.91 P/Share
|
|
Sep 07
2021
|
Richard Scott Struthers President & CEO |
SELL
Open market or private sale
|
Indirect |
30,000
-10.0%
|
$750,000
$25.0 P/Share
|
|
Jul 26
2021
|
Matthew K Fust |
SELL
Open market or private sale
|
Direct |
5,000
-28.51%
|
$95,000
$19.59 P/Share
|
|
Jul 26
2021
|
Matthew K Fust |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+22.19%
|
$5,000
$1.91 P/Share
|
|
Jul 19
2021
|
Matthew K Fust |
SELL
Open market or private sale
|
Direct |
5,000
-28.51%
|
$95,000
$19.5 P/Share
|
|
Jul 19
2021
|
Matthew K Fust |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+22.19%
|
$5,000
$1.91 P/Share
|
|
Jul 12
2021
|
Matthew K Fust |
SELL
Open market or private sale
|
Direct |
5,000
-28.51%
|
$100,000
$20.71 P/Share
|
|
Jul 12
2021
|
Matthew K Fust |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+22.19%
|
$5,000
$1.91 P/Share
|